Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Neoplasms and PKHD1[original query] |
|---|
| Germline PKHD1 mutations are protective against colorectal cancer. Human genetics 2011 Mar 129 (3): 345-9. Ward Christopher J, Wu Yanhong, Johnson Ruth A, Woollard John R, Bergstralh Eric J, Cicek Mine S, Bakeberg Jason, Rossetti Sandro, Heyer Christina M, Petersen Gloria M, Lindor Noralene M, Thibodeau Stephen N, Harris Peter C, Torres Vicente E, Hogan Marie C, Boardman Lisa |
| Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors. Cancer causes & control : CCC 2014 Jun 25 (6): 759-69. Huhn Stefanie, Bevier Melanie, Pardini Barbara, Naccarati Alessio, Vodickova Ludmila, Novotny Jan, Vodicka Pavel, Hemminki Kari, Försti As |
| Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area. Thyroid : official journal of the American Thyroid Association 2016 05 26 (5): 683-90. Jeon Min Ji, Chun Sung-Min, Kim Deokhoon, Kwon Hyemi, Jang Eun Kyung, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Jang Se Jin, Song Dong Eun, Kim Won |
| Tobacco habituated and non-habituated subjects exhibit different mutational spectrums in head and neck squamous cell carcinoma. 3 Biotech 2017 3 5 (5): 685-696. Rawal Rakesh M, Joshi Madhvi N, Bhargava Poonam, Shaikh Inayat, Pandit Aanal S, Patel Riddhi P, Patel Shanaya, Kothari Kiran, Shah Manoj, Saxena Akshay, Bagatharia Snehal |
| Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations. JCO precision oncology 2019 9 3 . Dumbrava E Ileana, Brusco L, Daniels M, Wathoo C, Shaw K, Lu K, Zheng X, Strong L, Litton J, Arun B, Eterovic A K, Routbort M, Patel K, Qi Yuan, Piha-Paul S, Subbiah V, Hong D, Rodon J, Kopetz S, Mendelsohn J, Mills G B, Chen K, Meric-Bernstam |
| Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11). Breast cancer research and treatment 2019 8 178 (2): 367-377. Kim Ji-Yeon, Lee Eunjin, Park Kyunghee, Im Seock-Ah, Sohn Joohyuk, Lee Keun Seok, Chae Yee Soo, Kim Jee Hyun, Kim Tae-Yong, Jung Kyung Hae, Park Yeon Hee, |
| Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer. American journal of clinical pathology 2019 Jul . Kishida Yoshihiro, Oishi Takuma, Sugino Takashi, Shiomi Akio, Urakami Kenichi, Kusuhara Masatoshi, Yamaguchi Ken, Kitagawa Yuko, Ono Hiroyu |
| Exome sequencing in 51 early onset non-familial CRC cases. Molecular genetics & genomic medicine 2019 2 7 (5): e605. Thutkawkorapin Jessada, Lindblom Annika, Tham Em |
| Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis. In vivo (Athens, Greece) 0 33 (2): 447-452. Lee Ju-Hee, Ahn Byung Kyu, Baik Seung Sam, Lee Kang Ho |
| Identification of PKHD1 mutations in Brain, Breast and Rectal tumors by Next Generation DNA Sequencing. The Gulf journal of oncology 2021 3 1 (35): 42-53. Mohammed Almehmadi Duaa, Saleh Dairi Abdulrhman, Ali Hassan Amal, Dannoun Anas, Saleh Banni Hussain, M Melibary Ehab, Youssef Abdel-Rahman, M Taher Mohiudd |
| The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma. PeerJ 2022 5 10 e13473. Ding Yubo, Yao Jingwei, Wen Meiling, Liu Xiong, Huang Jialu, Zhang Minghui, Zhang Yu, Lv Yufan, Xie Zhuoyi, Zuo JianHo |
| Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups. Frontiers in oncology 2022 11 12 1000146. Li Peng, Meng Qingyu, Xue Yonggan, Teng Zhipeng, Chen Hanlin, Zhang Junli, Xu Yang, Wang Sha, Yu Ruoying, Ou Qiuxiang, Wu Xue, Jia Baoqi |
| Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. Annals of gastroenterological surgery 2023 5 7 (3): 491-502. Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Sumiko Ohnami, Takeshi Nagashima, Ken Yamaguc |
| Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma. Clinical lymphoma, myeloma & leukemia 2023 2 . Zhang Rui, Wei Boyuan, Hu Yiyang, Lv Wenying, Adilai Abudurexiti, Yang Fan, Zhang Jianning, Cheng Ga |
| Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. Journal of Cancer 2024 7 15 (14): 4467-4476. Gang Ma, Binliang Huo, Yanwei Shen, Xulong Zhu, Chong Cheng, Wensheng Li, Wei Cao, Jianhui |
| Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic. Cells 2024 6 13 (12): . Farzana Jasmine, Maria Argos, Yuliia Khamkevych, Tariqul Islam, Muhammad Rakibuz-Zaman, Mohammad Shahriar, Christopher R Shea, Habibul Ahsan, Muhammad G Kibri |
| Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
- Page last reviewed:Feb 1, 2024
- Content source: